Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

President Obama Picks New York City Health Commissioner Thomas Frieden For CDC Director
President Obama on Friday appointed New York City Health Commissioner Thomas Frieden as CDC director, according to Obama administration officials, the New York Times reports. According to the Times, Frieden, an infectious disease specialist, has "cut a high and sometimes contentious profile" in his seven years as health commissioner in New York City, during which time he has advocated for a smoking ban in restaurants and bars, made HIV testing part of routine medical exams and protected a program that distributes 35 million condoms a year. According to the Times, Frieden is expected to take office next month. The Times reports that he will "inherit a host of immediate and long-term problems," including questions surrounding a vaccine for the H1N1 influenza virus, also known as swine flu, health care reform and organizational issues at CDC.The Times reports that a potential advantage for Frieden is a positive relationship with likely FDA Commissioner Margaret Hamburg, who also was New York City health commissioner. Frieden would work with Hamburg to combat the H1N1 flu virus and to re-evaluate the U.S. food safety system (Harris/Hartocollis, New York Times, 5/15).
generic viagra online
As College Drinking Problems Rise, New Studies Identify Effective Prevention Strategies
Alcohol-related deaths among U.S. college students rose from 1,440 deaths in 1998 to 1,825 in 2005, along with increases in heavy drinking and drunk driving, according to an article in the July supplement of the Journal of Studies on Alcohol and Drugs.
News of the day
Cubist Pharmaceuticals Initiates Phase 2 Trial In Europe For Therapy To Reduce Blood Loss During Surgery In High Risk Patients
Cubist Pharmaceuticals, Inc. (Nasdaq: CBST), a leading acute care therapeutics company, announced that it has begun dosing in the CONSERV™-2 clinical trial with ecallantide. CONSERV-2, being conducted in Europe, is a Phase 2 trial that will investigate ecallantide"s effect on surgical blood loss volume in cardiac surgery patients who are on cardiopulmonary bypass and are at a high risk of bleeding. The trial is expected to enroll 300 subjects.
Nutrition

Computer System For Dementia Patients

The labour force in the health services is shrinking, there are more and more old people, and a very high proportion of them are plagued by deteriorating short- and long-term memory. All this has created a need for computer-based solutions that will enable elderly people to live safely in their own homes, but at the same time, the technology needed to take special care of them is expensive. On top of this, different standards for home sensors create problems. This situation formed the backcloth for the EU"s decision a couple of years ago to launch a series of projects to make it simpler for industry to develop new equipment in this field. One of these projects was called Mpower, and its aim was to create a computer platform that could be used for various purposes and meet a wide range of needs among its target group. Reminder board What is being tested out in Norway today is a simple communication system based on a computer screen, aimed at elderly people who live at home but whose memory is failing. No keyboard is needed, only a touch on the screen, which displays the sun and the moon to indicate whether it is day or night, while a large clock-face shows the time. "This is also a system for sharing information", explains project manager Marius Mikalsen. The families of these patients are often anxious about how it is going with their parents, and this allows both them and the home help to enter messages that will be automatically displayed by the system. On the screen, for example, the elderly person might find "Remember to drink some water", or "Take the number 52 bus". Or current messages such as "The home help will be coming at nine o"clock this morning to give you a shower". Another useful feature is that family members can also access the system to check whether the elderly person"s appointments have been kept. Has she been to the doctor? Has he remembered to go to the day-care unit today? "SINTEF has been project manager here, and it is nice to think that what we are now testing in Norway was develop by the University of Cyprus in collaboration with two Spanish companies, and that it runs on a server in Austria," says Mikalsen. Trials Since last summer, a handful of elderly people have been trialling the system in Trondheim and Grimstad. Meanwhile, a variant of the system is being tested in a nursing home near Krakow in Poland. This version uses sensors and GPS to offer smart solutions both in the house and outdoors to sound the alarm if and elderly person is moving around in an unsafe area. Mpower will come to an end in June this year. SINTEF will try to prolong the project in collaboration with Trondheim"s local authorities. SINTEF


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009